OptiScan Biomedical's OptiScanner 5000 Receives 510(k) Clearance

OptiScan Biomedical won 510(k) clearance for the OptiScanner 5000 glucose monitoring system.

The device monitors plasma glucose levels and determines dysglycemia in surgical intensive care unit patients. The bedside system enables physicians to manage patient glucose levels in the ICU.

The device previously received CE Mark certification for use in the EU.